Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity (Q30835165)

27 June 2017

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity (English)

1 reference

27 June 2017

0 references

1 reference

1 reference

Robert L Shields

1

1 reference

27 June 2017

Jadine Lai

2

1 reference

27 June 2017

Rodney Keck

3

1 reference

27 June 2017

Lori Y O'Connell

4

1 reference

27 June 2017

Kyu Hong

5

1 reference

27 June 2017

Y Gloria Meng

6

1 reference

27 June 2017

Stefanie H A Weikert

7

1 reference

27 June 2017

Leonard G Presta

8

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of Biological Chemistry

27 June 2017

1 reference

27 June 2017

277

1 reference

27 June 2017

26733-26740

1 reference

27 June 2017

30

1 reference

describes a project that uses

27 June 2017

Lec13

0 references

cites work

Biological significance of carbohydrate chains on monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Effect of glycosylation on antibody function: implications for genetic engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

The IgG Fc receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

The C-type lectin superfamily in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Sialylation of human IgG-Fc carbohydrate by transfected rat alpha2,6-sialyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

On the interaction between agalactosyl IgG and Fc gamma receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Clinical trials of antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Recombinant human IgG molecules lacking Fcgamma receptor I binding and monocyte triggering activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Localization of the binding site for the human high-affinity Fc receptor on IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Fc receptors are required in passive and active immunity to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Antibody-cytokine fusion proteins for the therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Two Chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Humanization of an anti-p185HER2 antibody for human cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Characterization of complex formation by humanized anti-IgE monoclonal antibody and monoclonal human IgE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Fc receptors and their interactions with immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Multiple roles for the major histocompatibility complex class I- related receptor FcRn

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

The structure of a human type III Fcgamma receptor in complex with Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Crystallographic structure of an intact IgG1 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Refined structure of an intact IgG2a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Glycosidase inhibitors in study of glycoconjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Role of processing of N-linked oligosaccharides in control of immunoglobulin secretion from rat hybridomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202069200

Blood clearance in the rat of a recombinant mouse monoclonal antibody lacking the N-linked oligosaccharide side chains of the CH2 domains

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Introduction: bispecific antibodies

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Interaction of aglycosyl immunoglobulins with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Simple differentiation between core-fucosylated and nonfucosylated glycans by capillary electrophoresis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M202069200

Identifiers

DOI

10.1074/JBC.M202069200

1 reference

release_thqeqxvjlnhfvkzt2y7iysj5o4

27 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/thqeqxvjlnhfvkzt2y7iysj5o4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference